Protagenic Therapeutics, Inc.\new Operating Cash Flow
Protagenic Therapeutics, Inc.\new (PTIX) reported Operating Cash Flow of -$944.30 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-19
- Protagenic Therapeutics, Inc.\new net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$944.30K.
- Protagenic Therapeutics, Inc.\new net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $265.53K.
- Protagenic Therapeutics, Inc.\new net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$509.67K.
- Protagenic Therapeutics, Inc.\new net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$811.52K.
- Protagenic Therapeutics, Inc.\new net cash provided by (used in) operating activities for fiscal 2026 was -$2.81M.
- Protagenic Therapeutics, Inc.\new net cash provided by (used in) operating activities for fiscal 2025 was -$1.77M.
- Protagenic Therapeutics, Inc.\new net cash provided by (used in) operating activities for fiscal 2024 was -$4.22M.
- Protagenic Therapeutics, Inc.\new net cash provided by (used in) operating activities for fiscal 2023 was -$3.70M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$944.30K 10-Q · filed 2026-08-19 | -$678.76K derived: sum of 2 quarters · filed 2026-08-19 | -$1.19M derived: sum of 3 quarters · filed 2026-08-19 | -$2.00M derived: sum of 4 quarters · filed 2026-08-19 | |
| 2026-03-31 | $265.53K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-14 | -$244.13K derived: sum of 2 quarters · filed 2026-08-14 | -$1.06M derived: sum of 3 quarters · filed 2026-08-14 | -$2.81M 10-K · filed 2026-08-14 | |
| 2025-12-31 | -$509.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-09 | -$1.32M derived: sum of 2 quarters · filed 2026-03-09 | -$3.07M 10-Q · filed 2026-03-09 | -$4.14M derived: sum of 4 quarters · filed 2026-08-19 | |
| 2025-09-30 | -$811.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-26 | -$2.56M 10-Q · filed 2025-11-26 | -$3.63M derived: sum of 3 quarters · filed 2026-08-19 | -$3.98M derived: sum of 4 quarters · filed 2026-08-19 | |
| 2025-06-30 | -$1.75M 10-Q · filed 2026-08-19 | -$1.17M 10-QT · filed 2025-09-10 | -$2.82M derived: sum of 2 quarters · filed 2026-08-19 | -$3.17M derived: sum of 3 quarters · filed 2026-08-19 | -$3.49M derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-03-31 | -$1.07M 10-Q · filed 2025-05-13 | -$1.42M derived: sum of 2 quarters · filed 2026-03-09 | -$1.74M derived: sum of 3 quarters · filed 2026-03-09 | -$1.77M 10-K · filed 2026-08-14 | |
| 2024-12-31 | -$353.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-09 | -$671.08K derived: sum of 2 quarters · filed 2026-03-09 | -$917.51K 10-Q · filed 2026-03-09 | -$4.22M 10-K · filed 2025-03-31 | |
| 2024-09-30 | -$317.44K derived: 10-Q 6 month − 10-QT 3 month · filed 2025-11-26 | -$563.87K 10-Q · filed 2025-11-26 | -$3.40M 10-Q · filed 2024-11-14 | -$3.37M derived: sum of 4 quarters · filed 2025-11-26 | |
| 2024-06-30 | -$246.43K 10-QT · filed 2025-09-10 | -$3.21M 10-Q · filed 2024-08-14 | -$3.05M derived: sum of 3 quarters · filed 2025-09-10 | -$3.71M derived: sum of 4 quarters · filed 2025-09-10 | |
| 2024-03-31 | -$1.66M 10-Q · filed 2025-05-13 | -$2.80M derived: sum of 2 quarters · filed 2025-05-13 | -$3.46M derived: sum of 3 quarters · filed 2025-05-13 | -$4.99M derived: sum of 4 quarters · filed 2025-05-13 | |
| 2023-12-31 | -$1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$1.80M derived: sum of 2 quarters · filed 2025-03-31 | -$3.33M derived: sum of 3 quarters · filed 2025-03-31 | -$3.70M 10-K · filed 2025-03-31 | |
| 2023-09-30 | -$655.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$2.19M derived: sum of 2 quarters · filed 2024-11-14 | -$2.56M 10-Q · filed 2024-11-14 | -$2.74M derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | -$1.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$1.90M 10-Q · filed 2024-08-14 | -$2.08M derived: sum of 3 quarters · filed 2024-08-14 | -$2.62M derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | -$371.83K 10-Q · filed 2024-05-15 | -$552.77K derived: sum of 2 quarters · filed 2024-05-15 | -$1.09M derived: sum of 3 quarters · filed 2024-05-15 | -$1.94M derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | -$180.94K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-05-14 | -$716.17K derived: sum of 2 quarters · filed 2024-05-14 | -$1.56M derived: sum of 3 quarters · filed 2024-05-14 | -$1.99M 10-K/A · filed 2024-05-14 | |
| 2022-09-30 | -$535.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$1.38M derived: sum of 2 quarters · filed 2023-11-14 | -$1.81M 10-Q · filed 2023-11-14 | -$2.22M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | -$847.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$1.28M 10-Q · filed 2023-08-14 | -$1.68M derived: sum of 3 quarters · filed 2023-08-14 | -$2.76M derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | -$430.56K 10-Q · filed 2023-05-15 | -$835.65K derived: sum of 2 quarters · filed 2023-05-15 | -$1.91M derived: sum of 3 quarters · filed 2023-05-15 | -$2.62M derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | -$405.09K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$1.48M derived: sum of 2 quarters · filed 2023-03-31 | -$2.19M derived: sum of 3 quarters · filed 2023-03-31 | -$2.80M 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$1.79M derived: sum of 2 quarters · filed 2022-11-14 | -$2.39M 10-Q · filed 2022-11-14 | -$2.71M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | -$710.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$1.32M 10-Q · filed 2022-08-11 | -$1.64M derived: sum of 3 quarters · filed 2022-08-11 | -$2.16M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$607.71K 10-Q · filed 2022-05-13 | -$928.58K derived: sum of 2 quarters · filed 2022-05-13 | -$1.45M derived: sum of 3 quarters · filed 2022-05-13 | -$1.59M derived: sum of 4 quarters · filed 2022-05-13 | |
| 2020-12-31 | -$320.87K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-07 | -$838.68K derived: sum of 2 quarters · filed 2022-04-07 | -$984.37K derived: sum of 3 quarters · filed 2022-04-07 | -$1.35M 10-K · filed 2022-04-07 | |
| 2020-09-30 | -$517.81K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$663.50K derived: sum of 2 quarters · filed 2021-11-15 | -$1.03M 10-Q · filed 2021-11-15 | -$1.18M derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | -$145.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$510.10K 10-Q · filed 2021-08-16 | -$659.52K derived: sum of 3 quarters · filed 2021-08-16 | -$721.28K derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-03-31 | -$364.41K 10-Q · filed 2021-05-17 | -$513.83K derived: sum of 2 quarters · filed 2021-05-17 | -$575.59K derived: sum of 3 quarters · filed 2021-05-17 | -$656.38K derived: sum of 4 quarters · filed 2021-05-17 | |
| 2019-12-31 | -$149.42K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$211.18K derived: sum of 2 quarters · filed 2021-03-25 | -$291.98K derived: sum of 3 quarters · filed 2021-03-25 | -$487.99K 10-K · filed 2021-03-25 | |
| 2019-09-30 | -$61.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$142.56K derived: sum of 2 quarters · filed 2020-11-16 | -$338.57K 10-Q · filed 2020-11-16 | -$646.36K derived: sum of 4 quarters · filed 2020-11-16 | |
| 2019-06-30 | -$80.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$276.81K 10-Q · filed 2020-08-14 | -$584.60K derived: sum of 3 quarters · filed 2020-08-14 | -$744.23K derived: sum of 4 quarters · filed 2020-08-14 | |
| 2019-03-31 | -$196.01K 10-Q · filed 2020-06-18 | -$503.81K derived: sum of 2 quarters · filed 2020-06-18 | -$663.44K derived: sum of 3 quarters · filed 2020-06-18 | -$1.01M derived: sum of 4 quarters · filed 2020-06-18 | |
| 2018-12-31 | -$307.79K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-29 | -$467.42K derived: sum of 2 quarters · filed 2020-04-29 | -$812.18K derived: sum of 3 quarters · filed 2020-04-29 | -$1.07M 10-K · filed 2020-04-29 | |
| 2018-09-30 | -$159.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$504.39K derived: sum of 2 quarters · filed 2019-11-14 | -$763.40K 10-Q · filed 2019-11-14 | -$1.18M derived: sum of 4 quarters · filed 2019-11-14 | |
| 2018-06-30 | -$344.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$603.76K 10-Q · filed 2019-08-14 | -$1.02M derived: sum of 3 quarters · filed 2019-08-14 | -$1.38M derived: sum of 4 quarters · filed 2019-08-14 | |
| 2018-03-31 | -$259.01K 10-Q · filed 2019-05-16 | -$676.03K derived: sum of 2 quarters · filed 2019-05-16 | -$1.03M derived: sum of 3 quarters · filed 2019-05-16 | -$1.28M derived: sum of 4 quarters · filed 2019-05-16 | |
| 2017-12-31 | -$417.02K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | -$775.81K derived: sum of 2 quarters · filed 2019-03-29 | -$1.02M derived: sum of 3 quarters · filed 2019-03-29 | -$1.38M 10-K · filed 2019-03-29 | |
| 2017-09-30 | -$358.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$605.67K derived: sum of 2 quarters · filed 2018-11-08 | -$963.07K 10-Q · filed 2018-11-08 | -$1.30M derived: sum of 4 quarters · filed 2018-11-08 | |
| 2017-06-30 | -$246.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$604.28K 10-Q · filed 2018-08-14 | -$946.08K derived: sum of 3 quarters · filed 2018-08-14 | ||
| 2017-03-31 | -$357.40K 10-Q · filed 2018-05-15 | -$699.21K derived: sum of 2 quarters · filed 2018-05-15 | |||
| 2016-12-31 | -$341.81K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$1.14M 10-K · filed 2018-04-02 | |||
| 2016-09-30 | -$798.51K 10-Q · filed 2017-11-13 | ||||
| 2011-09-30 | -$74.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | -$7.75M 10-Q · filed 2011-11-14 | |||
| 2011-06-30 | -$7.68M 10-Q/A · filed 2011-09-07 | ||||
| 2010-09-30 | -$3.37M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | -$12.97M 10-Q · filed 2011-11-14 | |||
| 2010-06-30 | -$9.59M 10-Q/A · filed 2011-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |